Tepnel Appoints Nomura
September 12 2002 - 3:00AM
UK Regulatory
RNS Number:0700B
Tepnel Life Sciences PLC
12 September 2002
For Further Information:
Tepnel Life Sciences 0161 946 2200
Ben Matzilevich, CEO
Gron Ffoulkes-Davies, Finance Director
Nomura International plc
Charles Spicer, Head of Healthcare Corporate Finance 020 7521 2000
HCC De Facto Group
David Dible / Mark Swallow 020 7496 3300
Tepnel Life Sciences ('Tepnel') Appoints Nomura International plc as
Nominated Advisor and Broker
Notification of Results
Manchester, UK. 12 September 2002...Tepnel Life Sciences PLC (AIM: TED), the
UK-based international life sciences instrumentation and services company, is
pleased to announce that it has appointed Nomura International plc as its
nominated advisor and broker, with immediate effect.
Ben Matzilevich said, "We are very pleased to be working with Nomura, which has
significant international biotechnology and healthcare expertise. As a company,
we have global ambitions and we believe that Nomura can play a key role in the
next phase of our development and assist us in achieving our ambitious targets."
Tepnel will be announcing its results for the year ended 30 June 2002 on
Thursday, 26 September 2002.
-ends-
This information is provided by RNS
The company news service from the London Stock Exchange
EN
APPBKDKBOBKDDCD
Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024